ZNF484

gene
On this page

Also known as BA526D8.4FLJ33884

Summary

ZNF484 (zinc finger protein 484, HGNC:23385) is a protein-coding gene on chromosome 9q22.31, encoding Zinc finger protein 484 (Q5JVG2). May be involved in transcriptional regulation.

Predicted to enable DNA binding activity and zinc ion binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.

Source: NCBI Gene 83744 — RefSeq curated summary.

At a glance

  • GWAS associations: 5
  • Clinical variants (ClinVar): 118 total
  • MANE Select transcript: NM_031486

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:23385
Approved symbolZNF484
Namezinc finger protein 484
Location9q22.31
Locus typegene with protein product
StatusApproved
AliasesBA526D8.4, FLJ33884
Ensembl geneENSG00000127081
Ensembl biotypeprotein_coding
Entrez83744

Gene structure

Transcript identifiers

Ensembl transcripts: 8 — 8 protein_coding

ENST00000332591, ENST00000375495, ENST00000395505, ENST00000395506, ENST00000718324, ENST00000855340, ENST00000855341, ENST00000855342

RefSeq mRNA: 7 — MANE Select: NM_031486 NM_001007101, NM_001261458, NM_001261459, NM_001261460, NM_001354536, NM_001354537, NM_031486

CCDS: CCDS35066, CCDS35067, CCDS59136

Canonical transcript exons

ENST00000375495 — 5 exons

ExonStartEnd
ENSE000008699039285581192855903
ENSE000022588119287501592875059
ENSE000036852209285619292856318
ENSE000040347819287789092878038
ENSE000040347829284418292848551

Expression profiles

Bgee: expression breadth ubiquitous, 134 present calls, max score 87.67.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.8996 / max 215.3042, expressed in 1519 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1014535.89961519

Top tissues by expression

134 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
corpus callosumUBERON:000233687.67gold quality
calcaneal tendonUBERON:000370184.04gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047383.50gold quality
adrenal tissueUBERON:001830379.51gold quality
ganglionic eminenceUBERON:000402378.97gold quality
cortical plateUBERON:000534378.47gold quality
ventricular zoneUBERON:000305377.52gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099177.05gold quality
colonic epitheliumUBERON:000039775.54gold quality
islet of LangerhansUBERON:000000674.78gold quality
bone marrow cellCL:000209273.56silver quality
bone marrowUBERON:000237173.48gold quality
stromal cell of endometriumCL:000225573.33gold quality
tonsilUBERON:000237273.10gold quality
endometriumUBERON:000129572.43gold quality
superior frontal gyrusUBERON:000266172.04gold quality
cerebellar cortexUBERON:000212971.71gold quality
cerebellumUBERON:000203771.70gold quality
cerebellar hemisphereUBERON:000224571.56gold quality
right hemisphere of cerebellumUBERON:001489071.26gold quality
sural nerveUBERON:001548871.02gold quality
leukocyteCL:000073870.78gold quality
smooth muscle tissueUBERON:000113570.77gold quality
monocyteCL:000057670.59gold quality
prefrontal cortexUBERON:000045170.30gold quality
primary visual cortexUBERON:000243670.20gold quality
lymph nodeUBERON:000002969.63gold quality
urinary bladderUBERON:000125569.32gold quality
frontal cortexUBERON:000187068.91gold quality
placentaUBERON:000198768.90gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no4.45

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

68 targeting ZNF484, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3924100.0072.092394
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-1277-5P100.0073.955056
HSA-MIR-196A-1-3P99.9972.152772
HSA-MIR-428299.9975.366408
HSA-MIR-511-3P99.9968.851467
HSA-MIR-548P99.9872.253784
HSA-MIR-1213699.9872.815713
HSA-MIR-6888-3P99.9765.951170
HSA-MIR-60799.9773.625593
HSA-MIR-590-3P99.9674.346478
HSA-MIR-551B-5P99.9671.283493
HSA-MIR-10527-5P99.9172.283754
HSA-MIR-129799.9173.413162
HSA-MIR-3529-3P99.9073.553045
HSA-MIR-391999.8769.452489
HSA-MIR-548AR-3P99.8571.263889
HSA-MIR-548AZ-5P99.8369.943230
HSA-MIR-548T-5P99.8369.913220
HSA-MIR-449599.8272.083080
HSA-MIR-548AZ-3P99.8270.563549
HSA-MIR-548BC99.8270.613524
HSA-MIR-548E-3P99.8270.593514
HSA-MIR-548F-3P99.8270.593540
HSA-MIR-4799-5P99.8270.602663
HSA-MIR-4668-5P99.7970.583782
HSA-MIR-57799.7869.132479
HSA-MIR-548AG99.7769.251492
HSA-MIR-548A-3P99.7670.583524

Cross-species orthologs

0 orthologs

Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631), ZNF3 (ENSG00000166526)

Protein

Protein identifiers

Zinc finger protein 484Q5JVG2 (reviewed: Q5JVG2)

All UniProt accessions (1): Q5JVG2

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in transcriptional regulation.

Subcellular location. Nucleus.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

Isoforms (3)

UniProt IDNamesCanonical?
Q5JVG2-11yes
Q5JVG2-22
Q5JVG2-33

RefSeq proteins (7): NP_001007102, NP_001248387, NP_001248388, NP_001248389, NP_001341465, NP_001341466, NP_113674* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001909KRABDomain
IPR013087Znf_C2H2_typeDomain
IPR036051KRAB_dom_sfHomologous_superfamily
IPR036236Znf_C2H2_sfHomologous_superfamily

Pfam: PF00096, PF01352

UniProt features (77 total): strand 29, zinc finger region 19, helix 17, turn 5, cross-link 2, splice variant 2, chain 1, domain 1, sequence variant 1

Structure

Experimental structures (PDB)

13 structures.

PDBMethodResolution (Å)
2EMFSOLUTION NMR
2EMGSOLUTION NMR
2EMHSOLUTION NMR
2EMISOLUTION NMR
2EOVSOLUTION NMR
2EP1SOLUTION NMR
2EP2SOLUTION NMR
2EP3SOLUTION NMR
2EQWSOLUTION NMR
2YTJSOLUTION NMR
2YTOSOLUTION NMR
2YTPSOLUTION NMR
2YTSSOLUTION NMR

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q5JVG2-F160.520.11

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (2): 156, 816

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-212436Generic Transcription Pathway

MSigDB gene sets: 74 (showing top): GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, chr9q22, CUI_TCF21_TARGETS_2_DN, IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, LEE_BMP2_TARGETS_DN, PEDRIOLI_MIR31_TARGETS_UP, RAO_BOUND_BY_SALL4_ISOFORM_B, ARID5B_TARGET_GENES, ARNT2_TARGET_GENES, ATF5_TARGET_GENES, BARX1_TARGET_GENES, CIITA_TARGET_GENES, DIDO1_TARGET_GENES, E2F2_TARGET_GENES

GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)

GO Molecular Function (3): DNA binding (GO:0003677), zinc ion binding (GO:0008270), metal ion binding (GO:0046872)

GO Cellular Component (1): nucleus (GO:0005634)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
RNA Polymerase II Transcription1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
regulation of DNA-templated transcription1
transcription by RNA polymerase II1
DNA-templated transcription1
regulation of gene expression1
regulation of RNA biosynthetic process1
nucleic acid binding1
transition metal ion binding1
cation binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

312 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNF484SMIM9A6NGZ8638
ZNF484SMIM19Q96E16514
ZNF484MGAT4BQ9UQ53343
ZNF484CSTF2TQ9H0L4338
ZNF484INO80DQ53TQ3325
ZNF484RNF121Q9H920323
ZNF484PRRC2CQ9Y520316
ZNF484GTF2IRD1Q9UHL9308
ZNF484HMBOX1Q6NT76304
ZNF484AAMPQ13685301
ZNF484FOXN2P32314272
ZNF484STK36Q9NRP7265
ZNF484UQCRQO14949263
ZNF484COX7A2P14406254
ZNF484PCGF5Q86SE9247
ZNF484ENSAO43768247

IntAct

7 interactions, top by confidence:

ABTypeScore
ZNF484KRT8psi-mi:“MI:0915”(physical association)0.400
Mpsi-mi:“MI:0914”(association)0.350
ZNF484IPO8psi-mi:“MI:0914”(association)0.350
ZNF484ZNF195psi-mi:“MI:0914”(association)0.350
ZNF484psi-mi:“MI:0915”(physical association)0.000

BioGRID (13): ZNF484 (Affinity Capture-RNA), ZNF484 (Affinity Capture-RNA), ZNF484 (Proximity Label-MS), TRIM33 (Affinity Capture-MS), ARIH1 (Affinity Capture-MS), ZNF195 (Affinity Capture-MS), SMARCAD1 (Affinity Capture-MS), TRIM28 (Affinity Capture-MS), TRIM24 (Affinity Capture-MS), TRIM37 (Affinity Capture-MS), TRIM39 (Affinity Capture-MS), ZYG11A (Affinity Capture-MS), ZNF484 (Protein-peptide)

ESM2 similar proteins: A2VDP4, A6NHJ4, O94892, P0CJ79, P17014, P17021, P17025, P17032, P17035, P18733, P51508, P51814, Q06730, Q06732, Q09FC8, Q0VGE8, Q14586, Q32M78, Q3MIS6, Q5JVG2, Q5R4K8, Q5R9S5, Q5RBQ3, Q5RCJ2, Q5RER9, Q5TYW1, Q5VIY5, Q6P560, Q6PDB4, Q6ZMW2, Q6ZN06, Q6ZNA1, Q76KX8, Q7L2R6, Q86Y25, Q8N184, Q8N823, Q8N883, Q8N8J6, Q8NEP9

Diamond homologs: A0JPL0, A2VDP4, A6QLU5, A6QPT6, A8MQ14, A8MUZ8, A8MWA4, B1APH4, B2RXC5, E9PYI1, E9Q8G5, O75290, O94892, P08042, P0CH99, P0CI00, P17014, P17025, P17030, P17031, P17032, P17098, P21506, P51508, P51523, P51786, P51814, P52736, P52738, Q02525, Q03923, Q03936, Q06730, Q06732, Q0VCB0, Q13401, Q14587, Q16587, Q2M218, Q2M3X9

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

118 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance102
Likely benign6
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

997 predictions. Top by Δscore:

VariantEffectΔscore
9:92848547:CCCAT:Cacceptor_gain1.0000
9:92848548:CCAT:Cacceptor_gain1.0000
9:92848548:CCATC:Cacceptor_gain1.0000
9:92848549:CAT:Cacceptor_gain1.0000
9:92848549:CATC:Cacceptor_gain1.0000
9:92848551:TCTAA:Tacceptor_loss1.0000
9:92848552:C:CCacceptor_gain1.0000
9:92854094:C:CTacceptor_gain1.0000
9:92854095:A:Tacceptor_gain1.0000
9:92856190:A:ACdonor_gain1.0000
9:92856191:C:CCdonor_gain1.0000
9:92856191:CCCA:Cdonor_gain1.0000
9:92856316:TTC:Tacceptor_gain1.0000
9:92856317:TC:Tacceptor_gain1.0000
9:92856318:CC:Cacceptor_gain1.0000
9:92856319:C:CAacceptor_loss1.0000
9:92856319:C:CCacceptor_gain1.0000
9:92856320:T:Aacceptor_loss1.0000
9:92848550:AT:Aacceptor_gain0.9900
9:92854089:T:TCacceptor_gain0.9900
9:92854094:C:Tacceptor_gain0.9900
9:92855900:CATC:Cacceptor_gain0.9900
9:92855901:ATCCT:Aacceptor_loss0.9900
9:92855902:TC:Tacceptor_gain0.9900
9:92855903:CC:Cacceptor_gain0.9900
9:92855903:CCTGT:Cacceptor_loss0.9900
9:92855904:C:CCacceptor_gain0.9900
9:92855905:T:Aacceptor_loss0.9900
9:92855911:C:CTacceptor_gain0.9900
9:92856186:GCTT:Gdonor_loss0.9900

AlphaMissense

5727 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
9:92846600:G:CF729L0.999
9:92846600:G:TF729L0.999
9:92846602:A:GF729L0.999
9:92846684:A:CF701L0.999
9:92846684:A:TF701L0.999
9:92846686:A:GF701L0.999
9:92846768:G:CF673L0.999
9:92846768:G:TF673L0.999
9:92846770:A:GF673L0.999
9:92846852:A:CF645L0.999
9:92846852:A:TF645L0.999
9:92846854:A:GF645L0.999
9:92847255:A:GL511P0.999
9:92846432:G:CF785L0.998
9:92846432:G:TF785L0.998
9:92846434:A:GF785L0.998
9:92846516:G:CF757L0.998
9:92846516:G:TF757L0.998
9:92846518:A:GF757L0.998
9:92846751:A:GL679P0.998
9:92846825:G:CH654Q0.998
9:92846825:G:TH654Q0.998
9:92846936:G:CF617L0.998
9:92846936:G:TF617L0.998
9:92846938:A:GF617L0.998
9:92847104:G:CF561L0.998
9:92847104:G:TF561L0.998
9:92847106:A:GF561L0.998
9:92847272:A:CF505L0.998
9:92847272:A:TF505L0.998

dbSNP variants (sampled 300 via entrez): RS1000092652 (9:92849798 CTCTT>C), RS1000347631 (9:92877720 C>T), RS1000446508 (9:92850095 C>T), RS1000448579 (9:92871564 A>T), RS1000643068 (9:92878977 T>C), RS1000739784 (9:92871826 C>T), RS1000756193 (9:92849859 T>C), RS1000907012 (9:92857345 G>T), RS1001078312 (9:92878752 C>T), RS1001088301 (9:92871858 G>A,T), RS1001371921 (9:92851469 G>A), RS1001633797 (9:92870887 G>A), RS1001698708 (9:92851754 T>C), RS1001705699 (9:92874098 C>A,T), RS1001777840 (9:92873824 A>G)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

5 associations (top):

StudyTraitp-value
GCST001524_22Visceral adipose tissue/subcutaneous adipose tissue ratio2.000000e-06
GCST006979_360Heel bone mineral density2.000000e-23
GCST010725_16Malaria9.000000e-06
GCST010725_28Malaria6.000000e-06
GCST010725_95Malaria6.000000e-06

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0004767visceral:subcutaneous adipose tissue ratio
EFO:0009270heel bone mineral density

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

21 total (human), top 21 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arseniteincreases abundance, increases expression2
Particulate Matterdecreases reaction, increases expression, increases abundance2
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamidedecreases expression1
TAK-243increases sumoylation1
triphenyl phosphateaffects expression1
tris(1,3-dichloro-2-propyl)phosphateincreases expression1
cupric oxideincreases expression1
di-n-butylphosphoric acidaffects expression1
abrineincreases expression1
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amideincreases expression, decreases reaction1
jinfukangdecreases expression1
Resveratrolaffects cotreatment, increases expression1
Air Pollutantsincreases abundance, increases expression1
Arsenicincreases abundance, increases expression1
Vehicle Emissionsdecreases reaction, increases expression1
Benzo(a)pyreneaffects methylation1
Doxorubicindecreases expression1
Plant Extractsaffects cotreatment, increases expression1
Urethaneincreases expression1
Vanadatesdecreases expression1
Cadmium Chloridedecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.